These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25266662)

  • 1. Adhesion molecule-mediated hippo pathway modulates hemangioendothelioma cell behavior.
    Tsuneki M; Madri JA
    Mol Cell Biol; 2014 Dec; 34(24):4485-99. PubMed ID: 25266662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 regulation of endothelial cell proliferation and apoptosis via modulation of CD31 and VE-cadherin expression.
    Tsuneki M; Madri JA
    J Biol Chem; 2014 Feb; 289(9):5357-70. PubMed ID: 24425872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin: A novel marker and potential therapeutic target for human angiosarcoma.
    Tsuneki M; Kinjo T; Mori T; Yoshida A; Kuyama K; Ohira A; Miyagi T; Takahashi K; Kawai A; Chuman H; Yamazaki N; Masuzawa M; Arakawa H
    Cancer Sci; 2017 Nov; 108(11):2295-2305. PubMed ID: 28845553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway.
    Tsuneki M; Hardee S; Michaud M; Morotti R; Lavik E; Madri JA
    Lab Invest; 2015 Jul; 95(7):765-80. PubMed ID: 25961170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.
    Yan X; Su H
    Med Sci Monit; 2017 Apr; 23():1963-1972. PubMed ID: 28435150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines.
    Sachita K; Yu HJ; Yun JW; Lee JS; Cho SD
    J Oral Pathol Med; 2015 Nov; 44(10):785-91. PubMed ID: 25475012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 Influences Fibroblast Behaviors Via Modulation of Cell-Cell and Cell-Matrix Interactions, Affecting Survivin and Hippo Pathways.
    Tsuneki M; Madri JA
    J Cell Physiol; 2016 Mar; 231(3):731-43. PubMed ID: 26248063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of YM155, a selective small-molecule survivin suppressant, alone and in combination with docetaxel in human malignant melanoma models.
    Yamanaka K; Nakahara T; Yamauchi T; Kita A; Takeuchi M; Kiyonaga F; Kaneko N; Sasamata M
    Clin Cancer Res; 2011 Aug; 17(16):5423-31. PubMed ID: 21737502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS.
    Minoda M; Kawamoto T; Ueha T; Kamata E; Morishita M; Harada R; Toda M; Onishi Y; Hara H; Kurosaka M; Akisue T
    Int J Oncol; 2015 Sep; 47(3):891-9. PubMed ID: 26166250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells.
    Feng W; Yoshida A; Ueda T
    Biochem Biophys Res Commun; 2013 May; 435(1):52-7. PubMed ID: 23618862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.
    Tao YF; Lu J; Du XJ; Sun LC; Zhao X; Peng L; Cao L; Xiao PF; Pang L; Wu D; Wang N; Feng X; Li YH; Ni J; Wang J; Pan J
    BMC Cancer; 2012 Dec; 12():619. PubMed ID: 23267699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma.
    Zhang L; Zhang W; Wang YF; Liu B; Zhang WF; Zhao YF; Kulkarni AB; Sun ZJ
    Cell Death Dis; 2015 May; 6(5):e1771. PubMed ID: 26018732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary study of biological mechanism and apoptotic effect induced by YM155 in SUDHL-4 cell line].
    Liang W; Zhang WJ; Gao QM; Qin W; Lu HN; Huang BB; Xiu B; Liang AB
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(10):700-4. PubMed ID: 22781300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming erlotinib resistance in EGFR mutation-positive non-small cell lung cancer cells by targeting survivin.
    Okamoto K; Okamoto I; Hatashita E; Kuwata K; Yamaguchi H; Kita A; Yamanaka K; Ono M; Nakagawa K
    Mol Cancer Ther; 2012 Jan; 11(1):204-13. PubMed ID: 22075159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells.
    Iurlaro M; Demontis F; Corada M; Zanetta L; Drake C; Gariboldi M; Peiro S; Cano A; Navarro P; Cattelino A; Tognin S; Marchisio PC; Dejana E
    Am J Pathol; 2004 Jul; 165(1):181-9. PubMed ID: 15215174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.
    Tanaka I; Osada H; Fujii M; Fukatsu A; Hida T; Horio Y; Kondo Y; Sato A; Hasegawa Y; Tsujimura T; Sekido Y
    Oncogene; 2015 Jan; 34(1):73-83. PubMed ID: 24336325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells.
    Zhang W; Liu Y; Li YF; Yue Y; Yang X; Peng L
    Cell Physiol Biochem; 2016; 38(6):2426-37. PubMed ID: 27287458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aryl hydrocarbon receptor-dependent disruption of contact inhibition in rat liver WB-F344 epithelial cells is linked with induction of survivin, but not with inhibition of apoptosis.
    Svobodová J; Kabátková M; Šmerdová L; Brenerová P; Dvořák Z; Machala M; Vondráček J
    Toxicology; 2015 Jul; 333():37-44. PubMed ID: 25843524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues.
    Cheng XJ; Lin JC; Ding YF; Zhu L; Ye J; Tu SP
    Oncotarget; 2016 Feb; 7(6):7096-109. PubMed ID: 26771139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer.
    Yamanaka K; Nakata M; Kaneko N; Fushiki H; Kita A; Nakahara T; Koutoku H; Sasamata M
    Int J Oncol; 2011 Sep; 39(3):569-75. PubMed ID: 21674125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.